SCHEMBL2941350

SCHEMBL2941350

CC(C)CC1NC2(CCN(C(=O)c3ccco3)CC2)N(CC(=O)O)C1=O

nearest known ligand 0.50

Predicted protein targets (top 13)

geneUniProtsupporting neighboursconfidence
CYP2D6 P10635 9/20 0.50
ALDH1A1 P00352 13/20 0.49
CYP2C9 P11712 5/20 0.49
TSHR P16473 3/20 0.49
CYP1A2 P05177 2/20 0.49
CYP2C19 P33261 2/20 0.49
HIF1A Q16665 1/20 0.49
CYP3A4 P08684 8/20 0.46
USP2 O75604 7/20 0.46
CHRM2 P08172 1/20 0.44
TP53 P04637 1/20 0.43
MAPK1 P28482 1/20 0.43
SMN1; SMN2 Q16637 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1800729 0.87 CYP2D6 (0.50) CYP2D6ALDH1A1CYP2C9TSHRCYP1A2
SCHEMBL1803452 0.85 NPC1 (0.52) CYP2D6ALDH1A1CYP2C9TSHRCYP1A2
SCHEMBL1798461 0.83 CYP2D6 (0.48) CYP2D6ALDH1A1CYP2C9TSHRCYP1A2
SCHEMBL2936250 0.80 CHRM2 (0.48) ALDH1A1TSHRCHRM2SMN1; SMN2
SCHEMBL1800751 0.79 CYP3A4 (0.55) CYP2D6ALDH1A1CYP2C9TSHRCYP1A2
SCHEMBL4006029 0.79 CYP3A4 (0.55) CYP2D6ALDH1A1CYP2C9TSHRCYP1A2
Hydrochloric Acid SCHEMBL1802546 0.78 CYP3A4 (0.54) CYP2D6ALDH1A1CYP2C9TSHRCYP1A2
SCHEMBL1805280 0.77 ALDH1A1 (0.53) CYP2D6ALDH1A1CYP2C9TSHRCYP1A2
SCHEMBL1800591 0.77 CYP1A2 (0.47) CYP2D6ALDH1A1CYP2C9TSHRCYP1A2
SCHEMBL4006906 0.77 CYP2D6 (0.53) CYP2D6ALDH1A1CYP2C9TSHRCYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1730147-B1 SUBSTITUTED 1,4,8-TRIAZASPIRO[4,5]DECAN-2-ON COMPOUNDS FOR USE IN THE TREATMENT OF OBESITY GRUENENTHAL GMBH (DE) 2010-02-03 EP claimed